NCT04186624 - Effectiveness of Supervised Exercise Program in Subacromial Impingement Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 5, 2019

Primary Completion Date

July 1, 2020

Study Completion Date

August 1, 2020

Conditions

Subacromial Impingement Syndrome

Interventions

DRUG

Subacromial-subdeltoid bursa corticosteroid injection

1 ml (7 mg / ml) betamethasone and 4 ml of 0.5% bupivacaine will be given subacromial bursa-subdeltoid space. Injection will be performed ultrasound-guided while the patient is in sitting position with the lateral approach.

Trial Locations (1)

34899

Marmara University School of Medicine, Department of Physical Medicine and Rehabilitation, Istanbul